View Older Stories View More Recent Stories

Aug 2, 2024 05:30PM Avicanna Announces Changes of Auditors
Jul 11, 2024 07:30AM Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore
Jul 10, 2024 05:30PM Avicanna Announces Results of Annual General Meeting & Provides Corporate Update
Jun 19, 2024 05:30PM Avicanna General Meeting
Jun 19, 2024 07:30AM Avicanna Announces USPTO Issuance of Patent SEDDS Technology
Jun 18, 2024 07:45AM Avicanna to Present at the Life Science Investor Forum June 20th, 2024
May 14, 2024 07:35AM Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter
May 13, 2024 07:30AM Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
Apr 18, 2024 05:00PM Avicanna Announces Closing of Non-brokered Private Placement
Apr 10, 2024 08:37AM Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
Apr 2, 2024 07:30AM Avicanna Reports Full Year 2023 Audited Financial Results 
Mar 27, 2024 08:02AM Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
Mar 26, 2024 07:30AM Avicanna To Hold Full Year 2023 Earnings Conference Call
Feb 29, 2024 07:30AM Avicanna Hosts Symposium on Cannabinoid-based Medicine  
Feb 15, 2024 07:30AM Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company
Feb 13, 2024 07:30AM Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™
Feb 5, 2024 07:50AM Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company
Jan 30, 2024 07:30AM Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in Brazil
Nov 14, 2023 05:00PM Avicanna Reports Q3 2023 Results
Nov 13, 2023 05:30PM Avicanna Announces Appointment of Paul Fornazzari to Board of Directors
Nov 1, 2023 05:55PM Avicanna To Hold Third Quarter 2023 Earnings Conference Call
Oct 11, 2023 07:30AM Avicanna Provides Update on the Successful Launch of MyMedi.ca
Sep 1, 2023 05:30PM Retirement of Chandra Panchal, PhD from the Board of Directors
Aug 15, 2023 07:30AM Avicanna Reports Q2 2023 Financial Statement
Aug 1, 2023 07:30AM Avicanna Announces Closing of Acquisition and Launch of MyMedi.ca
Jul 28, 2023 07:30AM Avicanna is Pleased to Announce the Initial Network of Brands on the MyMedi.ca Platform
Jul 17, 2023 07:30AM Avicanna Subsidiary SMGH Exports Aureus Branded CBD and CBG Into Paraguay
Jun 28, 2023 07:30AM Avicanna Provides Corporate Update and Preliminary Q2 Results
Jun 26, 2023 07:30AM Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement for Avicanna’s Proprietary SEDDS Technology Capsules for Canadian and International markets
Jun 22, 2023 07:30AM Avicanna Sponsors New Medical Cannabis Education and Training Campaign in Canada with the Canadian Consortium for the Investigation of Cannabinoids (“CCIC”)
Jun 13, 2023 07:30AM Avicanna and Langara College Announce Cannabinoid-Based Translational Research Collaboration and NSERC Grant
May 29, 2023 07:30AM Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business
May 16, 2023 07:30AM Avicanna Reports Q1 2023 Financial Statement
May 4, 2023 07:30AM Avicanna and Northern Green Canada Execute Master Service Agreement to Operationalize MyMedi.ca
Apr 3, 2023 07:30AM Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2022
Mar 28, 2023 07:50AM Shoppers Drug Mart partners with Avicanna to transition Medical Cannabis by Shoppers 
Feb 7, 2023 07:43AM Avicanna Expands its Partnership with Viola Brands to the United Kingdom
Dec 14, 2022 07:33AM Avicanna and Santé Cannabis Initiate Real-World Evidence Study on Musculoskeletal Pain and Inflammation with the RHO Phyto™ CBG Transdermal Gel Topical Product
Nov 29, 2022 07:30AM Avicanna Commercializes ‘Influid’, a Proprietary Water-soluble technology in the Canadian Market
Oct 31, 2022 05:00PM Avicanna Announces Extension of Term Loan
Oct 20, 2022 07:30AM Avicanna Files Complete Patent Specifications Relating to a Novel Cannabinoid Formulation for Reducing Incidence of Seizures and Sudden Unexpected Death in Epilepsy
Oct 18, 2022 07:30AM Avicanna Introduces a New Medical Cannabis Education Online Portal, “Avicenna Academy” for Health Care Professionals
Sep 15, 2022 09:08AM Avicanna Expands its Epilepsy Research Program with a New Collaboration with the University of Toronto
Sep 1, 2022 07:30AM Avicanna Announces Results of Annual General and Special Meeting
Jul 20, 2022 07:30AM Avicanna and Ei. Ventures Enter into an Agreement to Develop and Commercialize Adaptogen Nutraceuticals
Jul 7, 2022 07:30AM Avicanna Completes its First Commercial Export of its Derma-Cosmetics Brand Pura H&W™ into the European Union
Jun 24, 2022 07:30AM Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa
Jun 21, 2022 07:00AM CEO Presenting on the Emerging Growth Conference on June 22 Register Now
Apr 28, 2022 07:30AM Avicanna Expands RHO PhytoTM Formulary with the Introduction of Cannabigerol (CBG) Products into the Canadian Market
Apr 13, 2022 07:00AM Avicanna Enters into Exclusive License and Supply Agreement with Major South American Pharmaceutical Company
View More Recent Stories View Older Stories